How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.
作者信息
Büchner T, Hiddemann W, Maschmeyer G, Ludwig W, Löffler H, Nowrousian M, Aul C, Heinecke A
机构信息
Department of Internal Medicine, University of Münster, Federal Republic of Germany.
出版信息
J Cancer Res Clin Oncol. 1990;116(1):97-9. doi: 10.1007/BF01612647.
Abstract
摘要
相似文献
1
How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.如何改善成人急性髓系白血病的治疗：德意志联邦共和国急性髓系白血病协作组的研究
J Cancer Res Clin Oncol. 1990;116(1):97-9. doi: 10.1007/BF01612647.
2
Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.低剂量高三尖杉酯碱和阿糖胞苷联合粒细胞集落刺激因子预处理对复发或难治性急性髓系白血病的疗效。
J Cancer Res Clin Oncol. 2011 Jun;137(6):997-1003. doi: 10.1007/s00432-010-0947-z. Epub 2010 Dec 9.
3
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.CPX-351在急性髓系白血病治疗格局中的作用：作用机制、疗效与安全性
Drugs. 2025 May 10. doi: 10.1007/s40265-025-02194-w.
4
5
6
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.用于预防和治疗急性髓性白血病患者感染性并发症的集落刺激因子。
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD008238. doi: 10.1002/14651858.CD008238.pub3.
8
[Difficulties of remission induction treatment of acute myeloblastic leukemia].
Sem Hop. 1974 May 26;50(25):1691-4.
9
[Quality of survival in patients with acute leukemia subjected to combination drug therapy].
G Clin Med. 1976 Mar-Aug;57(5-6):183-91.
10
[Treatment of acute myeloid leukemia].[急性髓系白血病的治疗]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(2):190-200.
引用本文的文献
1
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia.常规剂量阿糖胞苷与伊达比星治疗老年急性髓系白血病的疗效
Ann Hematol. 1994 Jun;68(6):279-83. doi: 10.1007/BF01695033.
本文引用的文献
1
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
Blood. 1982 Aug;60(2):454-62.
2
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.急性髓细胞白血病的治疗：B组癌症与白血病研究组的一项研究
Blood. 1981 Dec;58(6):1203-12.
3
A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia.
Blood. 1984 Apr;63(4):843-7.
4
A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Blood. 1984 May;63(5):1039-45.
5
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival.
Lancet. 1984 Feb 18;1(8373):379-82. doi: 10.1016/s0140-6736(84)90424-0.
6
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
J Clin Oncol. 1985 Dec;3(12):1583-9. doi: 10.1200/JCO.1985.3.12.1583.
7
8
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.雄激素、免疫疗法和化疗用于成人急性髓性白血病维持治疗的随机对照研究。欧洲癌症研究与治疗组织白血病-淋巴瘤组试验
Cancer. 1986 Aug 1;58(3):617-23. doi: 10.1002/1097-0142(19860801)58:3<617::aid-cncr2820580304>3.0.co;2-1.
9
10
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.维持化疗可延长成人急性非淋巴细胞白血病的缓解期。
J Clin Oncol. 1988 Apr;6(4):583-7. doi: 10.1200/JCO.1988.6.4.583.
Zotero 插件